Stocktoria
CapsoVision, Inc CV
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2025-07-02
CapsoVision, Inc statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Gross margin | 52.9% | 54.2% |
| Operating margin | -188.3% | -169.4% |
| Net margin | -186.8% | -169.3% |
| FCF margin | -169.4% | -172.2% |
| Return on assets | -139.4% | -118.4% |
| Return on equity | -190.9% | 15.4% |
| Current ratio | 3.77 | 8.24 |
| Revenue growth | 15.3% | — |
Source: SEC EDGAR filings · CIK 0001378325 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.